PTEN and endometrial cancer: Disruption of the canonical TGF-β1→SMAD2/3/4 axis attenuated TGF-β1-mediated PTEN down-regulation as did inhibition of TGF-β1-MEK-ERK1/2 signaling in type II endometrial cancer cells [47].